Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer.
Authors
Blanke, C D; Beer, T M; Todd, K; Mori, M; Stone, M; Lopez, C
Abstract
To determine the safety and efficacy of weekly high-dose oral calcitriol and docetaxel, given to patients with non-resectable, incurable pancreatic cancer.
Publication
Investigational new drugs, 2009, Vol 27, Issue 4, p374